Loading clinical trials...
Loading clinical trials...
People with epilepsy are at a higher risk for sudden unexpected death than the general population. Sudden unexpected death in epilepsy (SUDEP) is a major cause of death in this population, accounting for 10-50% of deaths for those with epilepsy. The risk for SUDEP is particularly high for those with refractory epilepsy. Several lines of evidence support a cardiac mechanism for SUDEP. This study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in this population and 2. whether these are increased above the general population in the same age group. Additionally, these data will be correlated to specific clinical data, including seizure history, anticonvulsant medications, and any accompanying clinical symptoms.
By employing long-term electrocardiographic monitoring, this study plans to determine: 1. the frequency and types of cardiac arrhythmias that occur in patients with uncontrolled seizures and 2. whether these are increased above the general population in the same age group. The specific aims: 1. Identify the types, frequency, and duration of cardiac arrhythmias that occur in patients with refractory epilepsy and compare these data to available normative data. 2. Correlate abnormal heart rates and rhythms to specific clinical data: 1. seizure type, 2. seizure frequency, 3. probable location of seizure onset in the brain, when such data are available, 4. duration of seizures, and 5. type(s) and number of anticonvulsant medications being used. 3. Correlate cardiac arrhythmias to clinical symptoms
Age
16 - 49 years
Sex
ALL
Healthy Volunteers
No
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
April 1, 2002
Primary Completion Date
June 1, 2007
Completion Date
January 1, 2010
Last Updated
October 18, 2016
19
ACTUAL participants
Medtronic REVEAL
DEVICE
Lead Sponsor
Thomas Jefferson University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06425029